Sixty-seven digoxin-containing sera were analyzed by both radioimmunoassay and EMIT. After some important modifications of the rr method, agreement between the two methods was very good. Reproducibility of the EMIT assay was excellent; daily variations in values found for control sera were quite small, and recovery of added digoxin was good. Slight hemolysis had negligible effects, but highly hemolyzed specimens gave low recoveries of digoxin.
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Serum digoxin is now frequently measured as an aid to the diagnosis of digoxin toxicity and in monitoring therapy with this important cardiac glycoside.
Until very recently, essentially all the methods used in such measurements were radioimmunoassays. Although these methods are adequately specific and sensitive, they have the disadvantages inherent to all radioisotopic methods when used in the routine clinical laboratory: special isotopic safety considerations, licensure requirements, decay of radiolabeled reagents, need for radiocounting equipment, and in the methodology itself, the obligatory separation of antibodybound from unbound isotope. In 1975, Chang et al. (1) announced the development of an EMIT1 (Enzyme-Multiplied Immunoassay Technique) for digoxin, which could simultaneously eliminate all these disadvantages without sacrifice of the speed, specificity, and sensitivity previously characteristic only of the radioimmunological methods. The EMIT technique (2), already widely used to detect many drugs in urine (3) (4) (5) and to measure anticonvulsants in the blood (6), differs from radioimmunoassays in that an enzyme-labeled drug (i.e., a drug covalently attached to an enzyme) rather than an isotope-labeled is used as the antigen competing with the unlabeled drug to be analyzed. The antibody bound to the labeled drug then sterically inhibits the enzyme activity; the higher the concentration of unlabeled drug, the more competition there is for binding sites on the antibody, and thus more release of enzymatic activity, which serves as the indicator for the immunologic competition.
Thus, there is no need to separate labeled from unlabeled drug (1) and the assay is "homogeneous" (2).
We have evaluated the accuracy and precision claimed for the EMIT digoxin assay and report our results here, together with information on some of its other relevant characteristics.
Materials and Methods

Materials.
The EMIT digoxin assay manual kit, containing all necessary reagents, was obtained from Syva Corp., 3181 Porter Drive, Palo Alto, Calif. 94304. The enzyme upon which the analytical system is based is a bacterial glucose-6-phosphate dehydrogenase, which, unlike the mammalian enzyme (EC 1. and (c) after preincubation of this reaction mixture, the labeled digoxin (digoxin/glucose 6-phosphate dehydrogenase conjugate) is added, the mixture is incubated at 30 #{176}C for 30 mm, and its absorbance measured at 340 nm.
When we used the procedure exactly as given in the kit directions, we encountered a number of problems with accuracy and reproducibility. Each source of error had then to be separately identified and corrected, and we consider these initial problems to be completely solved. Specifically, we made the following modifications:
(1) Some random errors were traced to inadequate mixing of some components as they were successively added to the reaction tubes. This was corrected by vortex-mixing the contents of each tube individually assoon as a new reagent was added, rather than be vortexing a whole rack at once as recommended in the directions.
(2) For the enzymatic incubations, we used a highly precise stirred water bath with which temperature could be maintamed at 30 ± 0.02 #{176}C, rather than the less precise dry-block incubators recommended in the directions. (4) We found the electronic diluter-pipettor supplied to use as a component of the Syva instrument package to be too inaccurate for use in the assay. The same proved to be true of a loan unit supplied as a replacement. Thus, the prediluted enzyme-digoxin conjugate was pipetted with a 5O0-jl "SMI Micro/pettor" (Scientific Manufacturing Industries, Emeryville, Calif. 94608) with very satisfactory precision.
(5) A "sample time" setting of 4 was used with the Gilford rapid sampler; this is equivalent to a cuvette flow-line volume of about 0.75 ml.
(6) The Gilford cuvette appeared to be highly susceptible to light-scattering errors caused by minute particles and air bubbles. This possibility of error is particularly critical be- (b) The de-ionizedwater usedin reconstituting the working reagents was first allowed to come to room temperature, filtered, and nitrogen was bubbled through the water to remove dissolved oxygen. Several liters could be so treated and the de-gassed water kept in a closed bottle with minimal air space.
(c) All reconstituted reagents were filtered with a Swinney syringe filter adapter, through a Gelman GA-8 cellulose acetate filter.
(d) Lens paper, rather than tissue paper, was used to wipe all pipettes and pipettors.
(e) About twice a week, a dilute solution of a surfactant (Brij 35, 2 drops/b ml water) was flushed through the cuvette system, followed by thorough flushing with filtered, de-gassed, de-ionized water.
Results
Comparison of EMIT with radioimrnunoassay.
As indicated above, we re-assayed sera by EMIT that already had been analyzed by radioimmunoassay. The period between the two analyses, never more than a week, was usually one or two days, during which the samples were kept at 5#{176}C. Because the prior radioimmunoassay analyses had been performed by BioScience Laboratories, and our results were compared to these only after completion of the EMIT analyses, this portion of the study actually constitutes a double-blind interlaboratory comparison between radioimmunoassay and EMIT digoxin determinations. Table 1 shows agreement between analyses of 67 such samples. From these data we calculated a correlation coefficient of 0.979. No appreciable positive or negative bias of either set of data relative to the other is evident.
Analytical recovery.
Digoxin was added to each of two digoxin-free sera to give seven different concentrations. The volume in which the added digoxin was dissolved in no case increased the volume of the serum by more than 2%. The analytical recoveries are shown in Table 2 .
Although the mean recoveries are satisfactory, we believe that some degree of pipetting error in adding the microliter quantities of the digoxin solution to the serum may account for much of the small dispersion of values from ideality.
Reproducibility.
Support for the suggestion stated in the preceding paragraph lies in the excellent reproducibility of which the EMIT assay is capable. Two sera from patients given therapeutic doses of digoxin were analyzed in replicate. Results are given in Table 3 .
Day-to-day variation. For this study we tabulated the daily variation in results for two commercial digoxin control sera Digoxmn-free whole blood was hemolyzed and added in several final concentrations to digoxin-containing serum. (In these experiments the hemoglobin concentrations should be considered only as a marker of degree of hemolysis rather than an implication that hemoglobin itself would have any effect on the results of digoxin assay). Table 5 shows the effect of gross hemolysis on the assay, far more hemolysis than would usually be accepted in any routine specimen. To digoxin-free sera with a constant high degree of hemolysis, various amounts of digoxin were added and the sera analyzed.
The results clearly indicate that, rather than producing falsely high values, the presence of gross hemolysis actually results in low recoveries. We presume that components of the hemolyzed cells interfere at some stage of the immunological-enzymatic reaction sequence.
We next assessed the effect of hemolysis such as might ordinarily be encountered in actual clinical specimens. Various amounts of -hemolyzed blood were added to aliquots of a clinical specimen of digoxin-contamning serum. (Even at the lowest supplementation, the hemolysis was clearly visible.)
The assay results (Table 6 ) indicate that the presence of "ordinary" amounts of hemolysis makes no appreciable difference in results. Comparison with Table 2 suggests that, at most, hemolysis produces a slight but acceptable degradation in the reproducibility of the analysis.
Discussion
Our data in this study indicate that the EMIT digoxin assay, when used with the relatively simple technical modifications we described, gives results that agree well with those obtained by the radioimmunoassay method with which it was compared. Replicate precision is excellent; day-to-day variations in values obtained for the same specimens were quite acceptable during the five weeks in which this variable was measured. Analytical recoveries were similarly very good. The usually acceptable degrees of hemolysis in clinical laboratory specimens have a negligible effect on results, although highly hemolyzed specimens probably should not be analyzed.
We have estimated the average net reagent cost per analysis to be about $2.50-$2.75, which will vary somewhat with the number of specimens analyzed. This estimate includes a standard curve plus two controls per run. About 20 net unknown specimens can easily be analyzed within 2.5 h by one technologist using this manual procedure. For the reasons enumerated in the introductory paragraphs and in the study above, we highly recommend the EMIT assay for analysis of serum digoxin.
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